Future Cannabis Strategy Conference Europe 2021

• Looking at the UK as the world’s leading jurisdiction for the CBD industry to create clear legal and regulatory frameworks
• Analysing the Novel Food authorisation process journey to understand the impact on those faced with challenges
• Committing to the Novel Food authorisation process initiative to ensure quality and safety to the consumer
• Predicting the CBD food and drink landscape post Novel Food Licence to prepare for the future of the cannabis market

Cannabis is a unique and complex plant containing many endogenous chemicals representing numerous chemical classes.

The complexity of the matrix makes detection and accurate quantification of cannabinoids and other organic compounds very challenging.

In this presentation we will address the techniques and the tips for addressing the common cannabis testing:

• Potency Test
• Terpenes Profile
• Multiresidues Analysis
• Residual Solvent Determination
• Heavy Metals Content

• Looking at the current operational markets to understand progress and developments in each
• Breaking down the current cannabis market across Europe and worldwide to measure current market penetration
• Pinpointing the opportunity in Asia Pacific Markets to branch out for global success
• Getting clear on legislations across each country to weigh up the import/export decision making process
• Breaking through legislative challenges cross-market to develop a successful launch plan

• Is it happy days for CBD after the European Court’s “not a narcotic” ruling?
• What can we understand from the CBD regulatory changes in Europe and the UK cross category?
• With regions, countries and continents at different stages of the CBD and legalised marijuana roadmap, is there a better approach we should take to achieve a unified CBD category moving forward?
• How can we develop a more centralised and consolidated approach to CBD and cannabis legalisation so that the category can grow?
• Where are we lacking in collaboration that is affecting the speed at which cannabis can be a widely accepted category?

• How CBD managed to become commodity in such pace.
• What options do you have besides price-war?
• How best companies tackled this issue in the past and what you can learn from that when building your business case

• Looking at medical needs to provide solutions for people who need the benefits that cannabinoid-based medicinal products bring
• Raising the right arguments to convince the lawmakers to think differently and pave way for progress
• Pushing for legal developments to allow patients to access cannabis as part of their treatment
• Creating a clear divide between wellness and medical to cater to different needs
• Breaking through the mindsets of lawmakers to make new and innovative legislations that have the power to change the course of medicine

• Study of 15 samples taken from the EU legal market
• Exploratory GC-MS analysis for the identification of the mayor constituents
• Pharmacopeia method used to identify and quantify Vitamin-E Acetate
• CBD quality control and label legitimacy

• Taking lessons from the US to explore potential for cannabis in consumer markets
• Looking at the opportunities and potential challenges facing consumer goods firms to approach hurdles more effectively
• Drawing on GlobalData’s extensive cannabis research to identify consumer needs, channels of distribution, industry opinions, and case studies of successful products.

• Finding opportunity in high quality ingredient cosmetics to offer products that indulge and benefit the consumer
• Pushing for recognition among beauty professionals and platforms to build trust for CBD integration
• Leveraging the success of a brand to create opportunity for growth worldwide
• Delivering products backed by strong messaging to ensure the consumer knows people come before profits
• Facing fierce competition in the CBD space to deliver a unique and much needed brand built for success

• What are mycotoxins and how do they occur?
• Why are mycotoxins (and other contaminants) of concern and why test for them?
• Exploring the analytical methods used to test for mycotoxins
• Highlighting laboratory quality and what to look for in your testing laboratory

• Learning learned from EVALI
• Product stewardship and collaboration opportunities for industry
• Safety considerations for delivery systems for CBD/THC inhalable products
• Navigation of regulatory requirements and integration of product stewardship for new product development
• Outwaiting the regulatory and governmental barriers to avoid delays when introducing cannabis smoking products to market

Between 2018 and 2019, cannabis licensed producers were in a race to expand their operations to all corners of the world. The COVID-19 pandemic and declining cannabis stock prices in 2020 lead to a major shift in international expansion, prompting cannabis companies to streamline their global strategy to focus on core jurisdictions and product categories. Join industry leaders Bruce Linton and Jonathan Sherman for a lively discussion on changes to the global cannabis landscape and an in-depth look at international market opportunities.

Topics include:

• Investigating a shift in strategy by major cannabis players from being first to market in every jurisdiction, to focusing on core regions
• Evaluating the key global markets major cannabis players are focused on for recreational use and why
• Understanding which regions and cannabis product categories investment dollars are most frequently directed to

• Europe is in a unique position to learn from North American innovation as cannabis brands move away from medical style packaging to retail worthy packaging
• Sustainability is at the forefront of all industries, however cannabis will lead the charge
• Print technology, technique, and the use of mixed materials to create profound brand awareness and long-lasting customer loyalty
• How the right package can cater to territory specific regulations on cannabis marketing and compliance

• Looking at vaping in the Regulatory & Public Affairs Arena – the common issues & challenges?
• Identifying key ‘learnings’ for what may lie ahead in the CBD & Cannabis sectors
• The challenges in building public awareness, understanding and acceptance in new technologies and products
• The challenges in ensuring reasonable and achievable regulatory outcomes
• The opportunities in a post Brexit world?

• Summarising the outcome of the UN vote on cannabis and how this affects CBD
• Updating on CosIng and permitted types of CBD extracts in cosmetics
• Outlininh EIHA’s low cost compliance option to obtain a coveted novel food license in the UK & EU

• The importance of brand builders in the growth and future of the industry
• Brand, consumer engagement and route to market and how they build success across the value chain
• Find consumer relevance after some false starts

• Looking at the development of the medical market to understand its potential in the UK and Europe
• Understanding the potential in clinics to treat patients with CBD products
• Pushing for social acceptance to use CBD for beneficial and alternative treatments
• Using global scientific expertise to provide a patient-oriented approach for real results
• Using education and certification to drive prescriptions that address priority medical conditions

• Leveraging two categories to create a unique hybrid of products set for success
• Using CBD infused no and low alcohol to create an authentic adult social experience
• Tapping into emerging trends to satisfy consumer demand and deliver products that delight
• Understanding the potential in premiumisation behind CBD to build a profitable category
• Making CBD a part of the brand’s purpose to better connect with the consumer for a stronger relationship

• GLP vs. ISO
• ISO is not enough?
• SOP as base for internal quality
• GLP is the key to grant transparency and generate institutional trust

• How TRIP have built a community of engaged CBD fans, without traditional marketing channels available
• Who is this new CBD consumer – having brought hundreds of thousands of newcomers to the category, how to find your tribe
• Omnichannel and digital first – navigating behaviours and demands of the CBD consumer post Covid

• Understanding the barriers when launching CBD beverages to the market in Europe, in order to identify emerging opportunities
• Finding ways to create and innovate with new products in the CBD space that are legally accepted
• Braving the market as a new entrant in Spain to inaugurate the category and aim for mass market success
• Coupling cannabis elements with trending flavors and ingredients to create products that attract and benefit the consumer

• What can we expect to see when we look at the potential of medical cannabis on the market?
• What growth can we expect to see in topical / non-prescription CBD products for consumers? Are we seeing an increase in over-the-counter CBD requests?
• Other than the wellness movement, what is driving the increasing demand for medical cannabis?
• What are the key concepts to consider when developing partnerships in order to cater for the increasing demand of quality cannabis?
• How can the industry work together help to create a reliable cannabis promoted eco-system?
• What areas of opportunity can we see that will allow the industry to tap into niches that are in need of cannabis?
• How can we create opportunities for hemp and cbd in the market to encourage faith from investors?

• Testing the bioavailability of CBD vape liquids
• Does CBD breakdown during the vape process?
• Are nicotine delivery methods effective for CBD products?
• Clinical trials are needed to support medicinal applications of CBD
• ACM’s experience in developing nicotine vaporizers and inhalers, and supporting the medicinal R&D of cannabis-based medicines

• Is there opportunity outside of the Europe, Canada and the USA?
• In a post-covid climate, should focus for growth be national or international?
• How can we enter new markets when there is no “one rule fits all” in terms of regulation?
• How can we educate consumers on a global scale of the benefits behind the cannabis market?

• Existing regulations in global markets
• Challenges in the global marketplace due to regulations
• Opportunities in the future

• Looking at the financial picture of CBD to foresee the growth in the category long term
• Getting the capital market’s view of the sector to understand the potential in cannabis
• Understanding the patterns emerging in the CBD industry to follow the financial pulling power behind it
• Following the signals in CBD to leverage its relevance globally behind rising shares
• Leveraging the growing capital and the belief in the cannabis sector to withstand the challenges from regulatory roadblocks

Putting consumer preference & perception first in products development – foundation for successful new format launches:

• Looking at different consumer profiles & reason-for-usage to understand the best CBD product formats
• Identifying the power of consumer perception to choose the right format for product creation
• Understanding what drives the consumer to try new products to create consumer loyalty and impulse sales
• Drawing from emerging trends in more CBD advanced regions or other active-ingredient-categories to better understand the link between format and sales figures

• Exploring the origins of the “stigma” around the cannabis industry to identify areas for change moving forward
• Tapping into the BLM social movement & the emergence of the “New Optimist” Consumer post-covid-19 to achieve greater market opportunity
• Debating the importance of socially-conscious cannabis & CBD brands to emerge as category leaders and gain higher levels of success

• Using hemp in innovative formats to offer wellness and balance
• Promoting calm to cure current consumer stresses the natural way
• Making cannabis accessible to consumers to encourage its adoption through daily practices
• Putting nature at the core of the brand to align with consumer demands for companies that care
• Creating a variety of products cross category to accompany the consumer in their quest for a better lifestyle

• Taking insights from the e-cigarette experience to devise a strategy for success in cannabis cross-category
• Using past lessons to create commercially successful products from evidence-based innovation
• Focussing on majority sales to develop a strategy built around consumer reaction
• Putting quality first to devise therapeutic applications that are built on consumer trust
• Overcoming challenges to launch and succeed in the current cannabinoid market